Structure |
Chemical Name |
CAS |
MF |
![1,4-PIPERIDINEDICARBOXYLIC ACID, 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, 1-(1,1-DIMETHYLETHYL) 4-METHYL ESTER](/CAS/20180703/GIF/1143534-94-4.gif) |
1,4-PIPERIDINEDICARBOXYLIC ACID, 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, 1-(1,1-DIMETHYLETHYL) 4-METHYL ESTER |
1143534-94-4 |
C17H30N2O6 |
 |
tert-butyl 3-(2-mercaptoethyl)piperidine-1-carboxylate |
1420866-00-7 |
C12H23NO2S |
 |
1-tert-Butyl2-methyl3-oxopyrrolidine-1,2-dicarboxylate |
130948-04-8 |
C11H17NO5 |
 |
Ethyl pyrazole-3-carboxylate |
5932-27-4 |
C6H8N2O2 |
 |
Cinchophennatrium |
5949-18-8 |
C16H12NNaO2 |
 |
3,8-Dihydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylic acid methyl ester |
85003-85-6 |
C16H12O6 |
![DiMethyl 4'-hydroxy-[1,1'-biphenyl]-3,5-dicarboxylate](/CAS/20150408/GIF/1245828-39-0.gif) |
DiMethyl 4'-hydroxy-[1,1'-biphenyl]-3,5-dicarboxylate |
1245828-39-0 |
C16H14O5 |
 |
4-Piperidinecarboxylic acid, 4-(phenylamino)-, methyl ester |
61085-80-1 |
C13H18N2O2 |
 |
METHYL 6-NITRO-1H-INDOLE-2-CARBOXYLATE |
136818-66-1 |
C10H8N2O4 |
 |
diethyl 5-bromopyridine-2,3-dicarboxylate |
110239-01-5 |
C11H12BrNO4 |
 |
Calcium-3-hydroxy-4-oxopyran-2,6-dicarboxylat |
831-53-8 |
C7H6CaO7 |
 |
Dinatriumpyridin-2,6-dicarboxylat |
17956-40-0 |
C7H3NNa2O4 |
![(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one](/CAS/GIF/112849-17-9.gif) |
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one |
112849-17-9 |
C39H66O3Si2 |
![1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180629/GIF/864686-28-2.gif) |
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
864686-28-2 |
C28H33N3O2 |
![(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20200119/GIF/528587-70-4.gif) |
(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one |
528587-70-4 |
C11H9FO2 |
 |
Larotaxel intermediate(A-3) |
156294-33-6 |
C31H36O10 |
 |
Flomoxef Intermediate OXA |
|
|
 |
Pantoprazole Sodium Intermediates |
|
|
 |
Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate |
154330-67-3 |
C14H13F2NO3S |
 |
Nevirapine intermediate |
|
|
 |
1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-dione |
1292836-19-1 |
C16H8Cl2F2N2O6 |
 |
Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. with (R)-alpha-methylbenzenemethanamine (1:1), monohydrate (9CI) |
65794-75-4 |
C11H18NO4P |
 |
Canagliflozin Intermediate epimers |
|
|
 |
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
C32H32N2O |
 |
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine |
133111-56-5 |
C21H20ClN |
![CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI)](/CAS/20150408/GIF/247068-81-1.gif) |
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) |
247068-81-1 |
C14H25NO3 |
 |
Lixivaptan intermediate-IV |
179063-21-9 |
C19H14ClN3O3 |
 |
Sugammadex sodium 7-Bromide intermediates |
|
|
 |
Remdesivir No. 5 intermediate |
|
|
 |
(r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
863453-61-6 |
C8H15NO5S |
 |
Flomoxef Intermediate KDFA |
|
|
![5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole](/CAS/GIF/368890-20-4.gif) |
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
![4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one](/CAS/GIF/122584-14-9.gif) |
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
 |
Pemetrexed intermediate |
|
|
 |
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
 |
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
 |
-- |
93360-08-8 |
C30H27N2O6P |
 |
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
![5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide](/CAS/GIF/89729-09-9.gif) |
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
![5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester](/CAS/GIF/147125-14-2.gif) |
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
 |
Sterolazole intermediate |
|
|
 |
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
 |
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
 |
Carbamazepine intermediate |
|
|
![3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one](/CAS/GIF/1214741-21-5.gif) |
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
 |
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
![BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE](/CAS/GIF/518047-98-8.gif) |
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
![2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine](/CAS2/GIF/181210-18-4.gif) |
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
 |
Flomoxef Intermediate NaMT |
|
|
![2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid](/) |
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
 |
Silicone intermediate |
|
|
 |
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
![a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate](/CAS/GIF/114869-97-5.gif) |
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
 |
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
 |
2-(Aminoacetylamino)-3-(o-chlorobenzoyl)-5-ethylthiophene |
50509-09-6 |
C15H15ClN2O2S |
 |
JLEQLXGZAIAEFX-VRQJEYPFSA-N |
1795790-92-9 |
C22H19N3O5 |
![5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid](/CAS/20180906/GIF/1422956-25-9.gif) |
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid |
1422956-25-9 |
C28H31ClN4O3 |
 |
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
![(R)-1-acetyl-5-[2-(phenylsulfonyl)ethyenyl]-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole](/CAS/20200611/GIF/180637-88-1.gif) |
(R)-1-acetyl-5-[2-(phenylsulfonyl)ethyenyl]-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole |
180637-88-1 |
C24H26N2O3S |
 |
Velpatasvir intermediate |
1378391-43-5 |
C44H55N3O13 |
 |
Zanamivir Amine |
130525-62-1 |
C11H18N2O7 |
 |
(1S,3R,4S)-Ethyl 4-AMino-3-((tert-butoxycarbonyl)aMino)cyclohexanecarboxylate Oxalate |
1093351-24-6 |
C16H28N2O8 |
 |
Vorapaxar |
900161-12-8 |
C29H34N2O5 |
 |
1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- |
491833-28-4 |
C15H22N2O3 |
 |
TF-BF |
209861-00-7 |
C24H22F2O5 |
 |
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
 |
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
 |
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
![(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone](/CAS/20180703/GIF/1027552-46-0.gif) |
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
 |
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
 |
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
 |
2,5-Dihydro-5-thioxo-1H-tetrazol-1-methansulfonsure |
67146-22-9 |
C2H4N4O3S2 |
 |
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
 |
4-MAR |
|
|
![3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine](/CAS/GIF/1022150-12-4.gif) |
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
 |
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
 |
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
![(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](/CAS/20180703/GIF/1701403-10-2.gif) |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
 |
Sugammadex sodium hexabromide intermediate |
|
|
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
![2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-](/CAS/GIF/852148-49-3.gif) |
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
 |
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
 |
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
 |
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
 |
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
 |
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
 |
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
![[402960-19-4],C9H18N2O2, 186.40](/CAS/20180808/GIF/850252-34-5.gif) |
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
 |
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
 |
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
 |
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
 |
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
![3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile](/CAS/20180601/GIF/941688-05-7.gif) |
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
941688-05-7 |
C17H18N6 |
 |
Lumacaftor Intermediate |
936727-68-3 |
C17H13ClF2N2O3 |
![tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate](/CAS/20200401/GIF/1350636-75-7.gif) |
tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate |
1350636-75-7 |
C11H21NO3S |
![3-[2-(3,4-Dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-on](/CAS/GIF/15462-91-6.gif) |
3-[2-(3,4-Dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-on |
15462-91-6 |
C22H26O6 |
![α-[4-[2-(Diethylamino)ethoxy]phenyl]-α-phenylphenethylalkohol](/CAS/GIF/73404-00-9.gif) |
α-[4-[2-(Diethylamino)ethoxy]phenyl]-α-phenylphenethylalkohol |
73404-00-9 |
C26H31NO2 |